학술논문

LONGER-TERM CONCIZUMAB PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A OR B WITH INHIBITORS: ≥1-YEAR (56-WEEK CUT-OFF) EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 EXPLORER7 TRIAL
Document Type
ConferencePaper
Source
HAEMOPHILIA. 29:99-99
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1351-8216